YAYüksel Atay

Yüksel Atay

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Yüksel Atay has a total of 345 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Neurocognitive, Social-Cognitive and Quality of Life Differences in Children with Advanced Heart Failure: A Single-Center Cross-Sectional Study

    by Didem Celik, Aysen Yaprak Kapkin, Nazli Burcu Ozbaran, Nagehan Demiral, Zulal Ulger Tutar, Umit Kahraman, Osman Nuri Tuncer, Ahmet Daylan, Yüksel Atay, Çağatay Engin, et al.

    Background: Children with heart failure (HF) are at risk of cognitive and psychiatric problems, and reduced health-related quality of life (QoL), yet data remain limited. This study compared neurocognition, social cognition, health-related quality of life, and psychiatric symptoms among children awaiting transplantation with or without ventricular assist devices (VADs), those who had undergone heart transplantation, and matched controls. Methods: Twenty-three patients at Ege University and 17 age- and sex-matched controls were assessed using the Schedule for Affective Disorders and Schizophrenia for School-Aged Children, Present and Lifetime Version (K-SADS-PL), Screen for Child Anxiety-Related Emotional Disorders (SCARED), Children’s Depression Inventory (CDI), Wechsler Intelligence Scale for Children–Fourth Edition (WISC-IV), Eyes Test, and Pediatric Quality of Life Inventory (PedsQL), evaluating psychiatric diagnoses, anxiety and depressive symptoms, cognition, social cognition, and health-related quality of life. Results: Diagnosis rates and CDI and SCARED child scores were comparable, but SCARED parent scores were significantly higher in the HF group. Patients scored significantly lower on most WISC-IV subtests (8 of 10) and all composite scores and the Eyes Test, indicating impaired social cognition. Child- and parent-reported PedsQL scores were significantly lower across all domains. Cognitive outcomes did not differ significantly across treatment subgroups, though these comparisons were underpowered. Conclusions: Children with HF show marked impairments in neurocognition, social cognition, and health-related quality of life versus healthy peers. Cognitive outcomes did not differ significantly across treatment subgroups, although these subgroup analyses (5–7 children per group) were underpowered and cannot establish the absence of a treatment effect. These findings underscore the need for integrated multidisciplinary care.

  • Open Access

    Outpatient presentation of ventricular fibrillation in paediatric left ventricular assist device patients: a case series with mechanistic insights

    by Eser Doğan, Zülal Ülger Tutar, Mehmet Baki Beyter, Şeyma Şebnem Ön, Meral Yılmaz, Burcugül Karasulu Beci, Burcu Büşra Acar Alkan, Hakan Kurt, Ertürk Levent, Çağatay Engin, et al.

    Background: Ventricular fibrillation in paediatric recipients of left ventricular assist devices is rare but potentially fatal; however, because systemic perfusion may be temporarily maintained by the mechanical support, haemodynamic deterioration may be delayed, leading to underrecognition and presentation in the outpatient setting rather than as an immediate in-hospital emergency. Methods: We report three paediatric left ventricular assist device recipients who developed outpatient malignant ventricular arrhythmias, each representing a distinct mechanistic category: structural, mechanical, and endocrine. Clinical presentation, diagnostic findings, and therapeutic responses were reviewed to highlight pathophysiologic heterogeneity and inform individualised management. Results: The first patient, with biopsy-proven arrhythmogenic right ventricular dysplasia, experienced recurrent ventricular fibrillation refractory to multiple antiarrhythmic agents, ultimately requiring heart transplantation. The second patient presented with ventricular fibrillation secondary to mechanical suction and interventricular septal contact; defibrillation and left ventricular assist device speed reduction restored a stable rhythm with no recurrence. The third patient developed polymorphic ventricular arrhythmias during amiodarone-induced thyrotoxicosis and succumbed to refractory electrical storm and multi-organ failure despite intensive endocrine and antiarrhythmic therapy. Conclusions: Outpatient ventricular fibrillation in paediatric left ventricular assist device recipients may result from diverse mechanisms, including myocardial structural disease, mechanical pump heart interaction, and systemic endocrine disturbances. Mechanism-guided management combining antiarrhythmic, mechanical, and metabolic interventions is essential for optimal outcomes. Continuous rhythm surveillance and readiness for immediate defibrillation are key to improving survival in this vulnerable group.

  • Kalp Cerrahisinde Miyokard Koruması

    by Osman Nuri Tuncer, Mahsati Akhundova, Mehmet Fatih Ayık, Yüksel Atay

  • Open Access

    Kalp ve Damar Cerrahi - Konjenital Kalp Cerrahisi (Cilt 3)

    by Merjem Purelku, Gamze Tanrıverdi, Ayşe Sarıoğlu, Canan Ayabakan, Osman Yılmaz, Tuğçin Bora Polat, Merve Maze Aydemir, Feyza Ayşenur Paç, Serçin Özkök, Uğur Dikkaş, et al.

  • Çocuklarda Ventrikül Destek Cihazları ve Yapay Kalp

    by Tahir Yağdı, Çağatay Engin, Yüksel Atay, Osman Nuri Tuncer, Mustafa Özbaran

  • Open Access

    Kalp ve Damar Cerrahisi (Cilt 1-2)

    by Ayşen Yaprak Kapkın, Hakan Hançer, Günseli Çubukçuoğlu Deniz, Cüneyt Konuralp, Serpil Nalbant, Mehmet Çakıcı, Deniz Süha Küçükaksu, Tümer Ulus, Onur Benli, Hafize Yalınız, et al.

  • Çocuklarda Kalp ve Kalp/Akciğer Transplantasyonu

    by Tahir Yağdı, Çağatay Engin, Yüksel Atay, Osman Nuri Tuncer, Mustafa Özbaran

  • Atriyoventriküler Septal Defektler (AVSD)

    by Osman Nuri Tuncer, Mehmet Fatih Ayık, Yüksel Atay, Emin Alp Alayunt

  • Open Access

    Mid-Term Functional Recovery after Surgical Correction of ALCAPA: A 16-Year Single-Center Experience

    by Mehmet B. Beyter, Eser Dogan, Osman N. Tuncer, Firat Ergin, Gulcin Kayan-Kasikci, Zulal Ulger, Erturk Levent, Yuksel Atay

    Purpose: This study aimed to assess perioperative features, early postoperative outcomes, and mid-term cardiac function in children with anomalous origin of the left coronary artery from the pulmonary artery (ALCAPA) undergoing surgical repair.Methods: A retrospective review of 23 patients treated surgically between 2007 and 2023 was conducted. Patients were categorized into infants (1 year). Clinical, operative, and echocardiographic data were analyzed, including left ventricular ejection fraction (LVEF) and mitral regurgitation (MR). Follow-up evaluations were performed at 1 and 6 months postoperatively.Results: The median age at surgery was 9 months. Early mortality occurred in 17.4%, with no late deaths during follow-up. Preoperative LVEF was significantly lower in infants than in older patients (p = 0.013). Among 19 survivors, LVEF improved markedly by 1 month and normalized in all patients by 6 months. MR was present in 89.5% preoperatively, with 47.3% showing moderate to severe grades. At 6 months, MR improved in most cases, with only 2 patients exhibiting residual moderate regurgitation and no severe cases.Conclusions: ALCAPA is a rare but surgically correctable condition. Early surgical intervention leads to significant recovery of ventricular function and regression of MR within the first 6 postoperative months.


  • Open Access

    Long-term follow-up of valved homografts in right ventricle-to-pulmonary artery reconstruction: A comprehensive case series

    by Osman Nuri Tuncer, Mahsati Akhundova, Eser Doğan, Yüksel Atay

    Background: This study aims to evaluate the long-term outcomes of patients undergoing right ventricle-to-pulmonary artery reconstruction with valved homografts. Methods: A total of 106 patients (49 males, 57 females; median age: 5 years; range, 2 to 49 years) who underwent right ventricle-to-pulmonary artery reconstruction between January 2002 and January 2024 were retrospectively analyzed. The study utilized cryopreserved homografts and surgical procedures were conducted under moderate hypothermic conditions using cardiopulmonary bypass. Homograft failure was defined as the need for reintervention or replacement. The primary outcome measures were overall survival, freedom from conduit replacement rate, and freedom from any required reinterventions rate. Results: The median follow-up was 7 years. The overall survival rate was 92.5%, with early mortality primarily due to low cardiac output. Freedom from reintervention rates were 90.8%, 84.8%, and 76.3% at three, five, and 10 years, respectively. Thirteen patients required conduit replacement, with pulmonary homografts showing improved durability. Risk factors for homograft failure included pulmonary valve regurgitation treatment, lower patient weight, younger age, and female sex. Conclusion: This study highlights the excellent survival and durability of valved homografts in cardiac reconstruction, with implications for patient management and surgical decision-making in complex congenital heart disease procedures.